L Garcia-Valdes1, C Campoy2, H Hayes3, J Florido4, I Rusanova2, M T Miranda5, H J McArdle3. 1. 1] The Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, UK [2] Department of Paediatrics, School of Medicine, University of Granada, Granada, Spain. 2. Department of Paediatrics, School of Medicine, University of Granada, Granada, Spain. 3. The Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, UK. 4. Department Obstetrics and Gynaecology, School of Medicine, University of Granada, Granada, Spain. 5. Department of Biostatistics, School of Medicine, University of Granada, Granada, Spain.
Abstract
BACKGROUND: Obesity is associated with decreased iron status, possibly due to a rise in hepcidin, an inflammatory protein known to reduce iron absorption. In animals, we have shown that maternal iron deficiency is minimised in the foetus by increased expression of placental transferrin receptor (pTFR1), resulting in increased iron transfer at the expense of maternal iron stores. OBJECTIVE: This study examines the effect of obesity during pregnancy on maternal and neonatal iron status in human cohorts and whether the placenta can compensate for decreased maternal iron stores by increasing pTFR1 expression. SUBJECTS/ METHODS: A total of 240 women were included in this study. One hundred and fifty-eight placentas (Normal: 90; Overweight: 37; Obese: 31) were collected at delivery. Maternal iron status was measured by determining serum transferrin receptor (sTFR) and ferritin levels at 24 and 34 weeks and at delivery. Hepcidin in maternal and cord blood was measured by ELISA and pTFR1 in placentas by western blotting and real-time RT-PCR. RESULTS: Low iron stores were more common in obese women. Hepcidin levels (ng ml(-1)) at the end of the pregnancy were higher in obese than normal women (26.03±12.95 vs 18.00±10.77, P<0.05). Maternal hepcidin levels were correlated with maternal iron status (sTFR r=0.2 P=0.025), but not with neonatal values. mRNA and protein levels of pTFR1 were both inversely related to maternal iron status. For mRNA and all women, sTFR r=0.2 P=0.044. Ferritin mRNA levels correlated only in overweight women r=-0.5 P=0.039 with hepcidin (r=0.1 P=0.349), irrespective of maternal body mass index (BMI). CONCLUSIONS: The data support the hypothesis that obese pregnant women have a greater risk of iron deficiency and that hepcidin may be a regulatory factor. Further, we show that the placenta responds to decreased maternal iron status by increasing pTFR1 expression.
BACKGROUND:Obesity is associated with decreased iron status, possibly due to a rise in hepcidin, an inflammatory protein known to reduce iron absorption. In animals, we have shown that maternal iron deficiency is minimised in the foetus by increased expression of placental transferrin receptor (pTFR1), resulting in increased iron transfer at the expense of maternal iron stores. OBJECTIVE: This study examines the effect of obesity during pregnancy on maternal and neonatal iron status in human cohorts and whether the placenta can compensate for decreased maternal iron stores by increasing pTFR1 expression. SUBJECTS/ METHODS: A total of 240 women were included in this study. One hundred and fifty-eight placentas (Normal: 90; Overweight: 37; Obese: 31) were collected at delivery. Maternal iron status was measured by determining serum transferrin receptor (sTFR) and ferritin levels at 24 and 34 weeks and at delivery. Hepcidin in maternal and cord blood was measured by ELISA and pTFR1 in placentas by western blotting and real-time RT-PCR. RESULTS: Low iron stores were more common in obesewomen. Hepcidin levels (ng ml(-1)) at the end of the pregnancy were higher in obese than normal women (26.03±12.95 vs 18.00±10.77, P<0.05). Maternal hepcidin levels were correlated with maternal iron status (sTFR r=0.2 P=0.025), but not with neonatal values. mRNA and protein levels of pTFR1 were both inversely related to maternal iron status. For mRNA and all women, sTFR r=0.2 P=0.044. Ferritin mRNA levels correlated only in overweight women r=-0.5 P=0.039 with hepcidin (r=0.1 P=0.349), irrespective of maternal body mass index (BMI). CONCLUSIONS: The data support the hypothesis that obese pregnant women have a greater risk of iron deficiency and that hepcidin may be a regulatory factor. Further, we show that the placenta responds to decreased maternal iron status by increasing pTFR1 expression.
Authors: Melissa F Young; Ian Griffin; Eva Pressman; Allison W McIntyre; Elizabeth Cooper; Thomas McNanley; Z Leah Harris; Mark Westerman; Kimberly O O'Brien Journal: J Nutr Date: 2011-11-23 Impact factor: 4.798
Authors: A Santacruz; M C Collado; L García-Valdés; M T Segura; J A Martín-Lagos; T Anjos; M Martí-Romero; R M Lopez; J Florido; C Campoy; Y Sanz Journal: Br J Nutr Date: 2010-03-08 Impact factor: 3.718
Authors: Thomas Walsh; Sean D O'Broin; Sharon Cooley; Jennifer Donnelly; John Kennedy; Robert F Harrison; Corinna McMahon; Michael Geary Journal: Clin Chem Lab Med Date: 2011-05-31 Impact factor: 3.694
Authors: L B Yanoff; C M Menzie; B Denkinger; N G Sebring; T McHugh; A T Remaley; J A Yanovski Journal: Int J Obes (Lond) Date: 2007-04-17 Impact factor: 5.095
Authors: L Gambling; R Danzeisen; S Gair; R G Lea; Z Charania; N Solanky; K D Joory; S K Srai; H J McArdle Journal: Biochem J Date: 2001-06-15 Impact factor: 3.857
Authors: Cora M Best; Eva K Pressman; Chang Cao; Elizabeth Cooper; Ronnie Guillet; Olivia L Yost; Jonathan Galati; Tera R Kent; Kimberly O O'Brien Journal: FASEB J Date: 2016-07-11 Impact factor: 5.191
Authors: L J Reynolds; R I Pollack; R J Charnigo; C S Rashid; A J Stromberg; S Shen; J M O'Brien; K J Pearson Journal: J Dev Orig Health Dis Date: 2017-05-09 Impact factor: 2.401
Authors: Sunmin Lee; Ronnie Guillet; Elizabeth M Cooper; Mark Westerman; Mark Orlando; Tera Kent; Eva Pressman; Kimberly O O'Brien Journal: Pediatr Res Date: 2015-09-18 Impact factor: 3.756
Authors: Mary Dawn Koenig; Elizabeth Klikuszowian; Kimberly O O'Brien; Heather Pauls; Alana Steffen; Victoria DeMartelly; Rungnapa Ruchob; Lauren Welke; Nefertiti Hemphill; Bazil LaBomascus; Lacey Pezley; Andrew McLeod; Bruni Hirsch; Carol Estwing Ferrans; Lisa Tussing-Humphreys Journal: J Nutr Date: 2020-06-01 Impact factor: 4.798